Avanos Medical, Inc. (AVNS) Stock

AVNS logo

Avanos Medical, Inc.

AVNS
Healthcare

Company profile

Avanos Medical reported revenue of $701.20 million for fiscal year 2025, up 1.9% from fiscal year 2024. In Q1 2026 (the quarter ended March 31, 2026) revenue was $182.20 million, up 8.8% from a year before. Its largest business segment, Specialty Nutrition Systems, brought in 62% of segment revenue in fiscal year 2025; North America was the largest region with 78%. In Q1 2026 it reported net income of $5.10 million, against net income of $6.60 million a year earlier. Our analysis of its filings shows revenue growing from $673.30 million in fiscal year 2023 to $701.20 million in fiscal year 2025, 2.1% a year on average.

What stands out

  • It reported a net loss in each of its last 3 fiscal years, after a profit of $50.50 million in fiscal year 2022; the loss narrowed from $392.10 million in fiscal year 2024 to $72.90 million in fiscal year 2025.
  • Revenue in fiscal year 2025 was the highest of the last 5 fiscal years.

Figures from company filings; latest fiscal year ended December 31, 2025.

Largest shareholders

  • BlackRock Advisors LLC14.00%
  • T. Rowe Price Investment Management, Inc.11.42%
  • Brown Investment Advisory & Trust Co.4.78%
  • Armistice Capital LLC4.29%
  • Armistice Capital LLC4.29%

Share of the company, as of May 18, 2026

How much revenue does Avanos Medical make?

Avanos Medical reported $701.20 million in revenue for fiscal year 2025, up 1.9% from $687.80 million in fiscal year 2024. In Q1 2026 revenue was $182.20 million.

What is Avanos Medical's largest business segment?

Specialty Nutrition Systems, with $432.90 million or 62% of segment revenue in fiscal year 2025. Next: Pain Management and Recovery (34%) and Corporate and Other (4%).

Where does Avanos Medical make most of its revenue?

North America: 78% of revenue by region in fiscal year 2025, followed by Europe, Middle East and Africa (15%).

What companies are similar to Avanos Medical?

Listed companies of a similar size in the same industry (targeted healthcare equipment) include Alcon Inc. (ALC), ResMed Inc. (RMD), Glaukos Corporation (GKOS), Penumbra, Inc. (PEN).

Has Avanos Medical made a profit in recent years?

Net income by fiscal year: FY2021, $6.30 million; FY2022, $50.50 million; FY2023, a loss of $61.80 million; FY2024, a loss of $392.10 million; FY2025, a loss of $72.90 million. It reported a net loss in 3 of these 5 years.

How has Avanos Medical's revenue changed over the last 5 fiscal years?

Revenue by fiscal year: FY2021, $587.00 million; FY2022, $684.10 million; FY2023, $673.30 million; FY2024, $687.80 million; FY2025, $701.20 million.

Company Information

SectorHealthcare
IndustryTargeted Healthcare Equipment
Founded2014
IPO DateJul 2, 2018
IPO StatusPublic
ExchangeNYSE
TimezoneAmerica/New_York (EST)
Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.

Data as of .

How to cite: DataPorium, “Avanos Medical, Inc. (AVNS)”, data as of May 18, 2026, https://dataporium.tech/stocks/AVNS

LinkedInLinkedInXXYouTubeYouTube